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The bacterial drug resistance (DR), widely spreading at 3 levels: 
resistant bacteria, R plasmids and resistant genes - is progressively 
worsening problem, more than before the introduction of the anti-
microbial drugs, because: 1. There is now a much greater population 
of aged, infirm and immunocompromised patients; 2. Numerous ad-
vanced medical and surgical procedures depend for success on the 
appropriate use of effective antimicrobials; 3. Many other aspects of 
our daily lives - food production, processing, storage, etc.- depend 
on antimicrobials (4,5). DR of clinically important bacteria is one of 
the factors determining antibiotic policy (global and regional) for a 
certain period (2,4). The results of DR of 1400 strains of pathogenic 
Gram-negative and Gram-positive bacteria, isolated in the period 
1972-1990 towards 35 antibacterial drugs are thoroughly analysed as 
follows: 1. Correlation between DR and the extent of the practical ap-
plication of the drugs; 2. Dependence of DR on the taxonomic appur-
tenance and the sources of the isolation of the strains; 3. Correlation 
between the resistance to beta-lactams and the production of beta-
lactamases; 4. Frequency of R plasmids registered by direct and mo-
bilized transfer and eluminat ion; 5. In vitro activity of new 
beta-lactams and 4-quinolones; 6. In vitro activity of the new antibio-
tics teicoplanin and mupirocin against Gram-positive bacteria. Wide 
application of some antibiotics in the human and the veterinary me-
dicine decreased considerably their efficacy: at the end of 1972/77 
period an increased frequency of polyresistant strains of many pa-
thogenic bacteria was observed. The data for ampicillin were rather 
demonstrative: MIC50 and MIC90 were constantly higher, thus reach-
ing quite elevated levels for Klebsiella bacteria (more than 1,024 resp. 
8,192 mg/L). A static, even lower levels of MICs were registered for 
streptomycin - antibiotic rarely used during the recent 15 years. This 
fact emphasized one of the approaches of the antibiotic policy - re-
storing of DR towards certain antibiotic after it has been excluded 
from the practice for a definite period of time. DR is dependent not 
only on taxonomic determination but also on sources of strain isola-
tion. As a rule, strains isolated from patients with urinary tract infec-
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tions are more resistant than those of other origin. Higher antibiotic 
concentrations in urine corresponds to selection of strong-resistant 
strains. Major part of strains, resistant to beta-lactams are beta -lac-
tamase-producers. There is a direct but not so highly expressed 
correlation between those two signs, thus suggesting different mech-
anisms of resistance. Certain percent of Gram-negative bacteria (22-
36%) are R-plasmid-carriers confirmed by direct and mobilized 
conjugative transfer and elimination. Major part of the R plasmids in-
clude several markers of resistance. A powerful antibacterial effect 
in vitro show the cephalosporins of 3 r d generation ceftazidime and 
ceftriaxone - at 0,5 resp. 0,125 mg/L supress all investigated strains. 
For the recent decade intensive attention is paid to the new 4-quino-
lones. In our studies pefloxacin and ciprofloxacin at concentrations 
0,5 resp. 0,12 mg/L inhibit 90% of all strains of Enterobacteriaceae. 
Lower activity is registered against Klebsiella, P.aeruginosa, S. aure-
us and coagulase-negative staphylococci. New antibiotics against 
cocci are recently suggested for clinical practice - teicoplanin, gly-
copeptide, and mupirocin - for local application. Both, methicillin-
sensitive (MS) and methicillin-resistant (MR) strains S. aureus, 
isolated in Bulgaria and England, are sensitive towards these two 
antibiotics (table 1). 
Table 1. In vitro activity of teicoplanin and mupirocin against 150 
MS and MR strains S.aureus 
MIC range MIC50 mg/L MIC90 
Teicoplanin England 0,5 -4,0 0,68 0,87 
Bulgaria 0,125-4,0 0,128 0,51 
Mupirocin England 0,001-0,25 0,03 0,03 
"Bulgaria 0,001-0,125 0,02 0,02 
However, resistance to these antibiotics has been reported, too 
(1,3,6). To summarize, we could admit that there is a constant com-
petition between antibacterial chemotherapy and pathogenic bac-
ter ia l chemotherapy and pathogenic bacteria possessing 
never-ending mechanisms of resistance. 
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